HRA000900
Title:
Research of NSCLC
Release date:
2021-06-03
Description:
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
disease of cellular proliferation
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Gao Shu Geng
Contact person:
Gao Shugeng
Email:
gaoshugeng@vip.sina.com
Description:
Dr of Cancer Hospital Chinese Academy of Medical Science
Individuals & samples
Submitter:   Gao Shugeng / gaoshugeng@vip.sina.com
Organization:   National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Submission date:   2021-06-02
Requests:   1